12:00 AM
 | 
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Phenserine: Began Phase I testing

Axonyx Inc. (AXYX), New York, N.Y.
Product: Phenserine
Business: Neurological
Therapeutic category: Neurotransmission
Target:...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >